• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者心肌梗死预防的知情共享决策项目:一项随机对照试验

Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial.

作者信息

Buhse Susanne, Mühlhauser Ingrid, Heller Tabitha, Kuniss Nadine, Müller Ulrich Alfons, Kasper Jürgen, Lehmann Thomas, Lenz Matthias

机构信息

Faculty of Mathematics, Informatics and Natural Sciences, Unit of Health Sciences and Education, University of Hamburg, Hamburg, Germany.

Department of Internal Medicine III, Endocrinology and Metabolic Diseases, Jena University Hospital, Jena, Germany.

出版信息

BMJ Open. 2015 Nov 13;5(11):e009116. doi: 10.1136/bmjopen-2015-009116.

DOI:10.1136/bmjopen-2015-009116
PMID:26567256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4654390/
Abstract

OBJECTIVE

To evaluate an informed shared decision-making programme (ISDM-P) for people with type 2 diabetes under high fidelity conditions.

DESIGN

Randomised, single-blinded trial with sham control intervention and follow-up of 6 months.

SETTING

Single-centre diabetes clinic providing care according to the national disease management programme in Germany.

PARTICIPANTS

154 people with type 2 diabetes without diagnosis of ischaemic heart disease or stroke.

INTERVENTIONS

The ISDM-P is executed by diabetes educators. Core component is a patient decision aid on the prevention of myocardial infarction supplemented by a 90 min group teaching session. The structurally equivalent control intervention addresses stress issues.

MAIN OUTCOME MEASURES

Primary outcome was risk comprehension, including realistic expectations about benefits and harms of interventions. It was assessed by a 12-item questionnaire after the teaching session when patients set and prioritise their treatment goals. Key secondary outcome was adherence to treatment goals, operationalised as achievement of individual goals and medication uptake. ISDM-P teaching sessions were video-taped to monitor intervention fidelity.

RESULTS

72 of 77 ISDM-P and 71 of 77 control patients completed the questionnaire (score 0-12). ISDM-P patients achieved higher levels of risk comprehension, mean score 8.25 vs 2.62, difference 5.63 (95% CI 4.82 to 6.44), and realistic expectations (score 0-6), 4.51 vs 0.85, 3.67 (3.23 to 4.11). More ISDM-P patients wished to take statins, 59.2% vs 30.4%, 28.7% (12.9% to 44.5%); more prioritised blood pressure control, 51.4% vs 25.7%, and fewer intensive glucose control, 33.3% vs 60%, p=0.002. More ISDM-P patients achieved their glycated haemoglobin goals, 95.8% vs 85.7%, 10.1% (0.6% to 19.5%). Achievement of prioritised goals and medication uptake were comparable between groups.

CONCLUSIONS

The ISDM-P on preventive measures in type 2 diabetes was effective under high fidelity conditions. Involvement of diabetes educators may facilitate implementation of the informed shared decision-making.

TRIAL REGISTRATION NUMBER

ISRCTN84636255.

摘要

目的

在高保真条件下评估一项针对2型糖尿病患者的知情共享决策项目(ISDM-P)。

设计

采用假对照干预的随机单盲试验,随访6个月。

地点

根据德国国家疾病管理项目提供护理的单中心糖尿病诊所。

参与者

154例未诊断出缺血性心脏病或中风的2型糖尿病患者。

干预措施

ISDM-P由糖尿病教育者执行。核心组成部分是一份关于预防心肌梗死的患者决策辅助工具,并辅以90分钟的小组教学课程。结构等效的对照干预措施关注压力问题。

主要结局指标

主要结局是风险理解,包括对干预措施利弊的现实期望。在教学课程结束后,当患者设定并确定其治疗目标时,通过一份12项问卷进行评估。关键次要结局是对治疗目标的依从性,具体表现为实现个人目标和药物摄取情况。ISDM-P教学课程进行了录像,以监测干预的保真度。

结果

77例ISDM-P患者中的72例和77例对照患者中的71例完成了问卷(评分0-12)。ISDM-P患者实现了更高水平的风险理解,平均得分8.25对2.62,差值5.63(95%CI 4.82至6.44),以及现实期望(评分0-6),4.51对0.85,3.67(3.23至4.11)。更多ISDM-P患者希望服用他汀类药物,59.2%对30.4%,差值28.7%(12.9%至44.5%);更多患者将血压控制列为优先事项,51.4%对25.7%,而将强化血糖控制列为优先事项的患者较少,33.3%对60%,p=0.002。更多ISDM-P患者实现了糖化血红蛋白目标,95.8%对85.7%,差值10.1%(0.6%至19.5%)。两组之间在实现优先目标和药物摄取方面相当。

结论

2型糖尿病预防措施的ISDM-P在高保真条件下是有效的。糖尿病教育者的参与可能有助于实施知情共享决策。

试验注册号

ISRCTN84636255。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a092/4654390/8e02b01d2343/bmjopen2015009116f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a092/4654390/8e02b01d2343/bmjopen2015009116f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a092/4654390/8e02b01d2343/bmjopen2015009116f01.jpg

相似文献

1
Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial.2型糖尿病患者心肌梗死预防的知情共享决策项目:一项随机对照试验
BMJ Open. 2015 Nov 13;5(11):e009116. doi: 10.1136/bmjopen-2015-009116.
2
Informed shared decision-making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial.基层医疗中2型糖尿病患者的知情共同决策项目:整群随机对照试验
BMJ Open. 2018 Dec 14;8(12):e024004. doi: 10.1136/bmjopen-2018-024004.
3
An evidence-based shared decision making programme on the prevention of myocardial infarction in type 2 diabetes: protocol of a randomised-controlled trial.基于证据的 2 型糖尿病心肌梗死预防共享决策方案:一项随机对照试验方案。
BMC Fam Pract. 2013 Oct 19;14:155. doi: 10.1186/1471-2296-14-155.
4
An informed shared decision making programme on the prevention of myocardial infarction for patients with type 2 diabetes in primary care: protocol of a cluster randomised, controlled trial.一项针对基层医疗中2型糖尿病患者预防心肌梗死的知情共同决策项目:一项整群随机对照试验方案
BMC Fam Pract. 2015 Mar 31;16:43. doi: 10.1186/s12875-015-0257-2.
5
Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: A randomized trial.他汀类药物选择决策辅助工具对西班牙2型糖尿病患者的影响:一项随机试验。
Patient Educ Couns. 2016 Feb;99(2):295-9. doi: 10.1016/j.pec.2015.08.032. Epub 2015 Sep 1.
6
7
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.预测2型糖尿病个体患者接受中等强度他汀类药物治疗后绝对血管风险降低情况的模型的开发与验证:盎格鲁-斯堪的纳维亚心脏结局试验、预防心脏病发作的抗高血压和降脂治疗试验以及阿托伐他汀糖尿病协作研究。
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):213-21. doi: 10.1161/CIRCOUTCOMES.115.001980. Epub 2016 May 11.
8
Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.帮助2型糖尿病患者做出治疗决策:他汀类药物选择随机试验。
Arch Intern Med. 2007 May 28;167(10):1076-82. doi: 10.1001/archinte.167.10.1076.
9
Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial.面向患者的决策辅助工具对糖尿病治疗目标优先级排序的影响:实用随机对照试验。
BMJ. 2014 Sep 25;349:g5651. doi: 10.1136/bmj.g5651.
10
Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis.29325例2型糖尿病患者心肌梗死或中风二级预防治疗目标的达成情况:一项德国/奥地利糖尿病综合护理项目(DPV)多中心分析
Cardiovasc Diabetol. 2016 May 3;15:72. doi: 10.1186/s12933-016-0391-8.

引用本文的文献

1
Effectiveness of shared decision-making for glycaemic control among type 2 diabetes mellitus adult patients: A systematic review and meta-analysis.共享决策对 2 型糖尿病成年患者血糖控制效果的系统评价和 Meta 分析。
PLoS One. 2024 Jul 31;19(7):e0306296. doi: 10.1371/journal.pone.0306296. eCollection 2024.
2
Shared Decision-Making in Cardiovascular Risk Factor Management: A Systematic Review and Meta-Analysis.共享决策在心血管危险因素管理中的应用:系统评价和荟萃分析。
JAMA Netw Open. 2024 Mar 4;7(3):e243779. doi: 10.1001/jamanetworkopen.2024.3779.
3
Decision aids for people facing health treatment or screening decisions.

本文引用的文献

1
An informed shared decision making programme on the prevention of myocardial infarction for patients with type 2 diabetes in primary care: protocol of a cluster randomised, controlled trial.一项针对基层医疗中2型糖尿病患者预防心肌梗死的知情共同决策项目:一项整群随机对照试验方案
BMC Fam Pract. 2015 Mar 31;16:43. doi: 10.1186/s12875-015-0257-2.
2
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.2015年2型糖尿病高血糖管理:以患者为中心的方法:美国糖尿病协会和欧洲糖尿病研究协会立场声明更新版
Diabetes Care. 2015 Jan;38(1):140-9. doi: 10.2337/dc14-2441.
3
决策辅助工具用于帮助面临医疗保健治疗或筛查决策的人。
Cochrane Database Syst Rev. 2024 Jan 29;1(1):CD001431. doi: 10.1002/14651858.CD001431.pub6.
4
Cardiovascular disease risk communication and prevention: a meta-analysis.心血管疾病风险沟通与预防:一项荟萃分析。
Eur Heart J. 2024 Mar 27;45(12):998-1013. doi: 10.1093/eurheartj/ehae002.
5
Shared decision making: a personal view from two kidney doctors and a patient.共同决策:两位肾病医生和一位患者的个人观点。
Clin Kidney J. 2023 Sep 13;16(Suppl 1):i12-i19. doi: 10.1093/ckj/sfad064. eCollection 2023 Sep.
6
HbA1c as a shared treatment goal in type 2 diabetes? A secondary analysis of the DEBATE trial.HbA1c 作为 2 型糖尿病的共同治疗目标?DEBATE 试验的二次分析。
BMC Prim Care. 2023 May 13;24(1):115. doi: 10.1186/s12875-023-02067-9.
7
Decision coaching for people making healthcare decisions.决策辅导:帮助人们做出医疗决策。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013385. doi: 10.1002/14651858.CD013385.pub2.
8
World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update.世界心脏联盟心房颤动路线图-2020 年更新版。
Glob Heart. 2021 May 27;16(1):41. doi: 10.5334/gh.1023.
9
Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 1.欧洲德语国家的心脏康复——来自德国、奥地利和瑞士的循证指南LLKardReha-DACH-第1部分。
J Clin Med. 2021 May 19;10(10):2192. doi: 10.3390/jcm10102192.
10
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2019年美国心脏协会/美国心脏病学会成人高血压临床绩效与质量指标:美国心脏病学会/美国心脏协会绩效指标特别工作组报告
J Am Coll Cardiol. 2019 Nov 26;74(21):2661-2706. doi: 10.1016/j.jacc.2019.10.001.
Interventions for enhancing medication adherence.
提高药物依从性的干预措施。
Cochrane Database Syst Rev. 2014 Nov 20;2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4.
4
Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial.面向患者的决策辅助工具对糖尿病治疗目标优先级排序的影响:实用随机对照试验。
BMJ. 2014 Sep 25;349:g5651. doi: 10.1136/bmj.g5651.
5
Shared decision-making behaviours in health professionals: a systematic review of studies based on the Theory of Planned Behaviour.卫生专业人员的共同决策行为:基于计划行为理论的研究系统评价
Health Expect. 2015 Oct;18(5):754-74. doi: 10.1111/hex.12176. Epub 2014 Feb 16.
6
Decision aids for people facing health treatment or screening decisions.为面临健康治疗或筛查决策的人群提供的决策辅助工具。
Cochrane Database Syst Rev. 2014 Jan 28(1):CD001431. doi: 10.1002/14651858.CD001431.pub4.
7
Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making.知识并非患者的力量:系统综述和主题综合分析患者报告的共享决策障碍和促进因素。
Patient Educ Couns. 2014 Mar;94(3):291-309. doi: 10.1016/j.pec.2013.10.031. Epub 2013 Nov 9.
8
An evidence-based shared decision making programme on the prevention of myocardial infarction in type 2 diabetes: protocol of a randomised-controlled trial.基于证据的 2 型糖尿病心肌梗死预防共享决策方案:一项随机对照试验方案。
BMC Fam Pract. 2013 Oct 19;14:155. doi: 10.1186/1471-2296-14-155.
9
Clinical effectiveness of a patient decision aid to improve decision quality and glycaemic control in people with diabetes making treatment choices: a cluster randomised controlled trial (PANDAs) in general practice.患者决策辅助工具改善糖尿病患者治疗选择决策质量和血糖控制的临床效果:一项在一般实践中的群组随机对照试验(PANDAs)。
BMJ Open. 2012 Nov 5;2(6). doi: 10.1136/bmjopen-2012-001469. Print 2012.
10
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.KDIGO 临床实践指南:糖尿病与慢性肾脏病(2012 年更新版)
Am J Kidney Dis. 2012 Nov;60(5):850-86. doi: 10.1053/j.ajkd.2012.07.005.